Pfizer Inc. (NYSE: PFE) Is About to Trade Ex-dividend

Pfizer Inc. (NYSE: PFE) has announced that it will soon trade ex-dividend. This announcement signals the company’s investors to make their moves. The ex-dividend date refers to the day before a company decides which of its shareholders will get a dividend. Pfizer’s dividend will be $0.40 per share. Pfizer announces the real-world benefits of IBRANCE […]

Pfizer Inc. (NYSE: PFE) Finds That Paxlovid Cannot Prevent COVID-19 Infection

Pfizer Inc. (NYSE: PFE) has found that its Paxlovid pill might not effectively prevent COVID-19 in people who have come in contact with infected individuals. Paxlovid is an oral drug which the Food and Drug Administration (FDA) approved for the treatment of COVID-19. In the study, the company gave the pill to people for five […]

Pfizer Inc. (NYSE: PFE) Has Produced 6 Million Paxlovid Pills

Pfizer Inc. (NYSE: PFE) announced that it surpassed the target that Albert Bourla, its CEO, set and developed 6 million Paxlovid pills. Paxlovid is an oral pill that treats COVID-19. The company also stated that it had sent these pills to 26 counties. It hopes to create about 120 million pills in 2022. Meanwhile, the […]

Pfizer Inc. (NYSE: PFE) Gets Breakthrough Therapy Designation For RSVpreF

The U.S Food and Drug Administration (FDA) has given Pfizer Inc. (NYSE: PFE) the Breakthrough Designation for RSVpreF, its vaccine for respiratory syncytial virus (RSV). The vaccine is for people aged 60 and above. This move comes after Pfizer conducted a Phase IIa clinical trial that looked into the efficacy, immunogenicity, and safety of the […]

Pfizer Inc. (NYSE: PFE) Study Shows The Company Gives Equitable Pay to Workers

Pfizer Inc. (NYSE: PFE) has stated for the third time that a compensation expert has recognized that the company offers equitable pay to workers. This announcement came after a study on gender-based pay worldwide and for U.S minorities. It used bonuses, merit increases, and base pay to assess payment equity. The study also adjusted for […]

Pfizer Inc. (NYSE: PFE) Drug, Paxlovid, Becomes Readily Available As Omicron Subsides

The Pfizer Inc. (NYSE: PFE) drug, Paxlovid, is becoming more available as the number of omicron infections dwindles. The drug which the Food and Drug Administration (FDA) approved had been difficult to obtain during the spike, leaving a gap for patients with mild cases of the disease. Meanwhile, Pfizer and BioNTech SE’s (NASDAQ: BNTX) omicron […]

Pfizer Inc. (NYSE: PFE) and Other Biotechnology Service Companies Could Reach a Market Capitalization of $151.10 Billion

Pfizer Inc. (NYSE: PFE) is among the companies in the biotechnology services market that analysts expect to grow in 2022. These companies could amass a market cap of $151.10 billion in 2022. Other significant players in this category include Precision for Medicine, BioAlps, Novo Nordisk, Pfizer, Fisher BioService, and Novartis. The FDA and CDC are […]

Pfizer Inc. (NYSE: PFE) Releases More Data on Its Oral Drug for COVID-19

Pfizer Inc. (NYSE: PFE) has released additional data from the clinical trial of its oral COVID-19 drug. The company found that Paxlovid, the antiviral, was 89% efficient in protecting high-risk populations from dying or hospitalization due to COVID-19. The total dose consists of three pills taken two times a day for five days. It prevents […]

New Approaches to Covid-19 Treatment Enter the Picture

The Covid-19 treatment response process includes a number of different major players, including Pfizer Inc (NYSE:PFE), BioNTech SE – ADR (NASDAQ:BNTX), Moderna Inc (NASDAQ:MRNA), AstraZeneca plc (NASDAQ:AZN), Novavax Inc (NASDAQ:NVAX), Halberd Corp (OTCMKTS:HALB), and Johnson & Johnson (NYSE:JNJ). The pandemic is under control. Or is it? In much of the developing world, this is far […]

Novartis (NYSE:NVS) Enters Agreement For Manufacture Of Pfizer Inc. (NYSE:PFE) And BioNTech’s (NASDAQ:BNTX) mRNA Vaccine

Novartis (NYSE:NVS) has entered an initial agreement with Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) for manufacturing support to boost production of their mRNA COVID-19 vaccine to help address supply shortages. This is an example of an unlikely collaboration between big pharmaceutical companies geared at the fight against the coronavirus pandemic. Novartis signs vaccine manufacturing […]

Pfizer Inc. (NYSE:PFE) And BioNTech’s (NASDAQ:BNTX) COVID-19 Vaccine Is Safe, Says WHO

The World Health Organisation has said that the Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) vaccine is safe for the elderly despite reports of deaths in Norway. WHO said that the deaths are not attributed to the vaccine and urged vaccination with the vaccine to continue. WHO says Pfizer vaccine is safe On Friday, WHO […]

Pfizer Inc. (NYSE:PFE) and BioNTech (NASDAQ:BNTX) Delivers 10,000 COVID-19 Doses in Chile As Vaccination Commences

Chile has received 10,000 initial doses of the Pfizer Inc. (NYSE:PFE) and BioNTech (NASDAQ:BNTX) COVID-19 vaccine and commenced vaccinations. The county becomes the first in South America to commence vaccinations against the coronavirus that has so far infected over 584,545 Chileans to date. Chileans skeptical about COVID-19 vaccine The first Chilean to receive the vaccine […]

Johnson & Johnson (NYSE:JNJ) Enrols 45,000 Subjects in the Study of Its Experimental COVID-19 Vaccine Candidate

Johnson & Johnson (NYSE:JNJ) has said that it enrolled around 45,000 participants for its late stage study of its single-dose COVID-19 vaccine candidate and anticipates interim data at the end of January 2021. ENSEMBLE Study enrolls 45,000 participants The pharmaceutical company seems to lag rivals such as Moderna Inc. (NASDAQ:MRNA) and Pfizer Inc. (NYSE:PFE) in […]

Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges

Pfizer Inc. (NYSE:PFE) has announced that it will ship only half of the initially expected coronavirus vaccine doses this year due to supply chain problems. The company is developing a COVID-19 vaccine in partnership with Germany-based BioNTech SE (NASDAQ:BNTX). Pfizer to deliver 50 million vaccine doses this year The pharmaceutical giant has slashed its initial […]

Pfizer Inc. (NYSE:PFE) To Use Own Distribution Channel For COVID-19 Vaccines Instead Of Government Channel

Pfizer Inc. (NYSE:PFE) is planning to go alone to distribute the COVID-19 vaccine in the US once the FDA approves it instead of distributing it through the designated government coordinator.  Officials have questioned whether there is an adequate supply of medical-grade freezers in the US at the point of use for vaccines that need storages […]